TVM Lawsuits Against Ethicon Continue to Grow

Women all around the country are continuing to file transvaginal mesh (TVM) lawsuits against manufacturers of this product that has caused serious complications that often lead to the need for surgical removal of the device. Erosion is a common issue that can lead to severe pelvic injuries.

Judge Won’t Overturn $11 Million TVM Award

A judge in New Jersey has ruled that a South Dakota woman’s trial against transvaginal mesh manufacturer Johnson & Johnson had overwhelming evidence and an appropriate jury, so the company’s plea to overturn the $11 million award was denied.

TVM Lawsuit Joint Conference to Take Place in July 2014

Women all around the country are continuing to file transvaginal mesh (TVM) lawsuits against manufacturers of the devices. In July 2014, a joint TVM status conference will take place in the U.S. District Court, Southern District of West Virginia where there are currently several federal litigations taking place.

AMS Launches Transvaginal Mesh Investigation Following FDA Warning

Earlier in 2014, the U.S. Food and Drug Administration sent a warning letter to American Medical Systems (AMS) following a growing number of lawsuits against the company due to faulty transvaginal mesh devices (TVM), and a statement from parent company Endo International PLC announced that AMS will move forward with the 522 postmarket surveillance study for the Elevate product.

Three of Four Major TVM Manufacturers Refuse to Settle

Women around the country are continuing to file transvaginal mesh (TVM) lawsuits against manufacturers of the devices that are used to treat pelvic organ prolapse (POP) and stress urinary incontinence because the mesh can lead to serious complications and require surgical removal.

American Medical Systems

TVM Manufacturer American Medical Systems Warned by FDA

American Medical Systems, which manufactures transvaginal mesh devices, received a warning letter from the U.S. Food and Drug Administration (FDA) regarding issues the organization found at a facility run by the company. These included risk analysis and process validation procedures.